Lifeboat Foundation

Decline of the immune system is one of the areas SENS are working on, with just over a week left for the Winter Fundraiser and Triple donation match now is the time to support their work!

Immunosenescence is a key process in aging and rejuvention or replacement of the thymus which gradually wastes away as we age exposing us to pathogens is an important step in dealing with age-related diseases. SENS is working on these problems so if you want to see solutions please consider donating to our Winter Fundraiser today on the link below:

http://www.sens.org/donate

Continue reading “Immune Restoration Results from Placing a Young Thymus into an Aged Mouse” »

Light therapy kills cancer in new no surgery, no chemo approach.

A new non-surgical treatment for low-risk prostate cancer can effectively kill cancer cells while preserving healthy tissue, reports a new UCL-led phase III clinical trial in 413 patients. The trial was funded by STEBA Biotech which holds the commercial license for the treatment.

The new treatment, ‘vascular-targeted photodynamic therapy’ (VTP), involves injecting a light-sensitive drug into the bloodstream and then activating it with a laser to destroy tumour tissue in the prostate. The research, published in The Lancet Oncology, found that around half (49%) of patients treated with VTP went into complete remission compared with 13.5% in the control group.

Continue reading “Light therapy effectively treats early prostate cancer” »

The biotech battle between China and the US has begun as we predicated when we announced the first CRISPR deployment in humans last month. The US has upped the ante and is taking a step further in the race for the biotech crown. All great news for us as the more competition the faster progress will move so let’s hope there is a fierce battle for biotech coming.

In 2015, a little girl called Layla was treated with gene-edited immune cells that eliminated all signs of the leukemia that was killing her. Layla’s treatment was a one-off, but by the end of 2017, the technique could have saved dozens of lives.

It took many years to develop the gene-editing tool that saved Layla, but thanks to a revolutionary method known as CRISPR, this can now be done in just weeks.

Continue reading “CRISPR gene editing human trials in China and US offer hope for countless lives” »

Google Tech Talk with the SENS Research Foundation!

Commentary about our recent Google Tech Talk about the MitoSENS project from FightAging!

“As the clock ticks on this year’s SENS rejuvenation research fundraiser — less than two weeks to go now, and plenty left in the matching fund for new donations — it is good to be reminded of the progress that the SENS Research Foundation has accomplished with the charitable funding of recent years. With that in mind, today I’ll point you to a recent Google Tech Talk that provides a layperson’s introduction to one of the projects that our community has funded, fixing the problem of mitochondrial damage in aging. The point of the SENS (Strategies for Engineered Negligible Senescence) research programs is to accelerate progress towards specific forms of therapy that can bring aging under medical control.”

Continue reading “Presenting Mitochondrial Rejuvenation at a Google Tech Talk” »

Aging as a disease or Uber-disease is gaining traction and pressure is mounting on the WHO to include it as it fits their definition of a disease state.

Failing to classify aging as a disease is slowing progress and costing lives. We need to change the paradigm.

Tissue engineering and Stem cells are a large part of the rejuvenation biotechnology toolkit. Here we have yet more progress and this time the pacemaker cells are replicated for possible use in biological pacemaker therapies.

“Scientists from the McEwen Centre for Regenerative Medicine, University Health Network, have developed the first functional pacemaker cells from human stem cells, paving the way for alternate, biological pacemaker therapy.”

Lysosomes originally thought to be the dust bins of the body have recently been found to have some constructive roles too.

A new role has been discovered for a well-known piece of cellular machinery, which could revolutionise the way we understand how tissue is constructed and remodelled within the body.

Lysosomes are small, enzyme-filled sacks found within cells, which break down old cell components and unwanted molecules.

Continue reading “New construction role found for cell demolition tool” »

(FoxNews.com) — Food producer Del Monte has received approval from the Food and Drug Administration to start selling a genetically engineered pineapple with pink flesh.

The new species Ananas comosus has been given the more consumer-friendly name of the “Rosé” and, according to The Packer, Del Monte has quietly been working on the fruit’s development since 2005.

So what makes the usually golden-colored fruit pink? The patened pineapple DNA is injected with a healthy dose of lycopene, the bright red pigment found in tomatoes and watermelons.

A 14-year-old girl who said before dying of cancer that she wanted a chance to live longer has been allowed by the high court to have her body cryogenically frozen in the hope that she can be brought back to life at a later time.

The court ruled that the teenager’s mother, who supported the girl’s wish to be cryogenically preserved, should be the only person allowed to make decisions about the disposal of her body. Her estranged father had initially opposed her wishes.

During the last months of her life, the teenager, who had a rare form of cancer, used the internet to investigate cryonics. Known only as JS, she sent a letter to the court: “I have been asked to explain why I want this unusual thing done. I’m only 14 years old and I don’t want to die, but I know I am going to. I think being cryo‐preserved gives me a chance to be cured and woken up, even in hundreds of years’ time.

Continue reading “14-Year-Old Girl Who Died of Cancer Wins Right to be Cryogenically Frozen” »